4//SEC Filing
Kavanaugh William Michael 4
Accession 0001140361-17-045842
CIK 0001501989other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 2:35 PM ET
Size
6.9 KB
Accession
0001140361-17-045842
Insider Transaction Report
Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
- Exercise/Conversion
Common Stock
2017-12-08$1.57/sh+5,130$8,079→ 19,047 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-12-08−5,130→ 240,912 totalExercise: $1.57Exp: 2025-02-08→ Common Stock (5,130 underlying)
Footnotes (1)
- [F1]This option vests 25% on January 9, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001578767
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 2:35 PM ET
- Size
- 6.9 KB